Genus (GNS)

Sector:

Pharma and Biotech

Index:

FTSE 250

1,736.00p
   
  • Change Today:
      32.00p
  • 52 Week High: 2,774.00
  • 52 Week Low: 1,637.00
  • Currency: UK Pounds
  • Shares Issued: 66.03m
  • Volume: 30,232
  • Market Cap: £1,146.31m
  • RiskGrade: 128

Income Statement - Normalised

  £ (Millions) £ (Millions) £ (Millions) £ (Millions) £ (Millions)
30-Jun-23 30-Jun-22 30-Jun-21 30-Jun-20 30-Jun-19
Continuing Operations          
Revenue 689.70 593.40 574.30 551.40 488.50
           
EBITDA 101.40 90.60 103.90 38.80 74.10
Depreciation & Amortisation (30.20) (26.40) (35.10) (24.00) (26.30)
           
Operating Profit/(Loss) 71.20 64.20 68.80 14.80 47.80
Interest Payable (15.40) (6.60) (5.40) (5.30) (4.70)
Interest Receivable/Investment Income 1.10 0.40 0.40 0.30 0.80
           
Group Profit after Interest 53.00 58.00 63.80 26.20 43.90
Share of Assoc Cos/JV Profits 10.50 5.20 13.10 44.80 7.60
           
Profit Before Tax 63.50 63.20 76.90 71.00 51.50
Tax (17.40) (21.60) (14.60) (10.60) (12.70)
           
Profit After Tax 46.10 41.60 62.30 60.40 38.80
           
Discontinued Operations          
Profit After Tax n/a n/a n/a n/a n/a
           
PROFIT FOR PERIOD 50.00 41.60 62.30 56.80 38.80
           
Attributable to:          
Equity Holders of Parent Company 51.50 45.80 62.80 56.40 39.90
Minority Interests 1.50 4.20 0.50 (0.40) 1.10
           
Equity Dividends cn/a cn/a cn/a cn/a cn/a
Retained Profit/(Loss) for the Financial Year c51.50 c45.80 c62.80 c56.40 c39.90


Per Share Record - Normalised 30-Jun-23 30-Jun-22 30-Jun-21 30-Jun-20 30-Jun-19
Continuing EPS          
Earnings per Share - Basic 72.61p 70.04p 96.45p 92.44p 63.19p
Earnings per Share - Diluted 72.12p 69.70p 95.64p 91.70p 61.10p
Earnings per Share - Adjusted 84.80p 82.70p 100.90p 77.30p 73.20p
Continuing and Discontinued EPS          
Earnings per Share - Basic 78.56p 70.04p 0.97p 86.89p 15.79p
Earnings per Share - Diluted 78.03p 69.70p 0.96p 86.20p 15.26p
Earnings per Share - Adjusted 84.80p 82.70p 100.90p 77.30p 73.20p
           
Dividend per Share 32.00p 32.00p 32.00p 29.10p 27.70p


Key Financals 30-Jun-23 30-Jun-22 30-Jun-21 30-Jun-20 30-Jun-19
Shares in Issue (millions)          
Shares in Issue - Year End 66.03 65.77 65.76 65.09 65.05
Weighted Average 65.56 65.39 65.11 64.91 63.14
Diluted 66.00 65.71 65.66 65.43 65.30
           
Performance Ratios          
Continuing Operations          
Operating Margin 10.32% 10.82% 11.98% 2.68% 9.79%
Return on Capital Employed 11.50% 10.28% 0.15% 13.89% 2.86%
Continuing Operations & Discontinued Operations          
Return on Equity 8.09% 7.04% 0.11% 9.85% 1.78%
           
Financial Status          
Continuing Operations          
Interest Cover - Continuing 5.12 10.58 15.24 14.40 11.96
Revenue per Share 1,052.06p 907.41p 8.90p 849.51p 193.28p
Pre-Tax Profit Per Share - Continuing 96.86p 96.64p 1.19p 109.39p 20.38p
           
Market Data          
Continuing Operations          
Earnings Per Share Growth - Basic 4% -27% 4% 46% 88%
Earnings Per Share Growth - Diluted 4% -27% 4% 50% 84%
PE Ratio - Company Adjusted 29.8 35.8 51.4 38.2 41.9
PEG - Company Adjusted 7.5 n/a 12.9 0.8 0.5
Dividend Cover 2.27 2.19 3.01 3.18 2.28
Continuing Operations & Discontinued Operations          
Earnings per Share - Company Adjusted 12% 7,093% -99% 450% -53%
Earnings per Share - Diluted 12% 7,119% -99% 465% -54%
PE Ratio - Company Adjusted 27.6 35.8 5,094.4 40.6 167.7
PEG - Company Adjusted 2.3 0.0 n/a 0.1 n/a
Dividend Cover 2.45 2.19 0.03 2.99 0.57
           
Market Capitalisation £ (Millions) 1,430.15 1,649.60 3,261.77 2,299.04 1,722.64
Dividend per Share 32.00p 32.00p 32.00p 29.10p 27.70p
Dividend Yield 1.5% 1.3% 0.6% 0.8% 1.0%
Dividend per Share Growth n/a n/a 9.97% 5.05% 42.05%

Key

* GAAP

a. Includes discontinued activities

b. Includes preference dividends

c. Not disclosed under IFRS

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: Forecast figures based on normalised accounts.

 

Top of Page